Mettrum Health Corp.

December 12, 2014 11:32 ET

Mettrum Receives Health Canada License at its Agripharm Facility

TORONTO, ONTARIO--(Marketwired - Dec. 12, 2014) - Mettrum Health Corp. ("Mettrum" or "the Company") (TSX VENTURE:MT)(TSX VENTURE:MT.WT), parent company of Mettrum Ltd., a licensed producer of medical cannabis under the Marihuana for Medical Purposed Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the "MMPR") and a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of medical cannabis products, is pleased to announce that the Company's subsidiary, Agripharm Corp. ("Agripharm"), has received a license from Health Canada to produce marijuana under the MMPR. This is Mettrum's second license under the MMPR.

The license authorizes Agripharm to grow 9,000 marihuana plants at its facility located on 80 acres of appropriately-zoned land in Clearview, Ontario, prior to its scheduled renewal date of June 11, 2015. Mature plants will be transferred to Mettrum Ltd. where they will be processed into dried marihuana, quality-assured and sold. Its first crop is expected in early 2015 and Agripharm is concurrently working to expand its growing area and other permitted activities under the MMPR license as issued on December 11, 2014.

"The licensing of our Agripharm facility ensures our ability to continue providing high quality medical cannabis to our existing customers and new customers," said Michael Haines, Chief Executive Officer of Mettrum. "We're looking forward to taking on new customers beyond our current registered customer base of approximately 2,100 patients and providing access to a legal source of medical cannabis for Canadians who have received authorization from their physician."

Agripharm was purchased by Mettrum in June 2014 and has a state-of-the-art facility that utilizes modular construction techniques, allowing for rapid expansion of capacity as required.

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., the wholly owned subsidiary of the Company, is a Toronto-based company incorporated under the laws of the Province of Ontario and a licensed producer under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license from Health Canada on November 1, 2013 and began production of medical cannabis on the same date at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada on December 11, 2014 for its acquired Agripharm facility in Clearview, Ontario. With the Company's two licenses, Mettrum is a leading producer and vendor of medical marijuana under the MMPR system.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

Contact Information